P&T - UMR 1248
Pharmacology and Transplantation
Organ transplantation repairs broken human being. It is among the most promising techniques to repair any single damaged part of a body in the near future. The INSERM U1248 P&T (Pharmacology and Transplantation, ex-IPPRITT) unit is part of the hospital-university “Survival oPtimization in ORgan Transplantation” (FHU SUPORT) federation.
Owing to its translational research strategy, as led by clinicians, biologists, pharmacologists and physical-chemists, IPPRITT has developed both basic and clinical research programmes and tools to improve transplant patient care. The findings (mainly in pharmacology) are transferred to the clinics, aiming at the development of personalized medicine.
Last submissions
-
Jean‐baptiste Woillard, Clément Benoist, Alexandre Destere, Marc Labriffe, Giulia Marchello, et al.. To be or not to be, when synthetic data meet clinical pharmacology: A focused study on pharmacogenetics. CPT: Pharmacometrics and Systems Pharmacology, 2024, Online ahead of print. ⟨10.1002/psp4.13240⟩. ⟨hal-04747078⟩
-
-
Laure Ponthier, Bénédicte Franck, Julie Autmizguine, Marc Labriffe, Philippe Ovetchkine, et al.. Application of machine-learning models to predict the ganciclovir and valganciclovir exposure in children using a limited sampling strategy. Antimicrobial Agents and Chemotherapy, 2024, pp.e0086024. ⟨10.1128/aac.00860-24⟩. ⟨hal-04700415⟩